Clinical Trial

Salivary Cortisol and Hypercortisolism in Type 2 Diabetes

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to explore the prevalence of hypercortisolism in a population with difficult to control type 2 diabetes despite receiving standard-of-care therapies. Additionally, the study will evaluate the correlation between salivary cortisol levels and glycemic control.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-04.
Trial Details
NCT Number NCT07156370
Lead Sponsor Shanghai 6th People's Hospital
Conditions Hypercortisolism, Type 2 Diabetes (T2DM)
Enrollment 500 participants
Start Date 2025-09-11
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-27